| Attribute |
Value |
| 52 Week Change |
0.3549981 |
| Address1 |
614 McKinley Place N.E. |
| All Time High |
135.9625 |
| All Time Low |
0.078125 |
| Ask |
77.06 |
| Ask Size |
2 |
| Audit Risk |
8 |
| Average Analyst Rating |
2.7 - Hold |
| Average Daily Volume10 Day |
8,889,500 |
| Average Daily Volume3 Month |
4,698,073 |
| Average Volume |
4,698,073 |
| Average Volume10Days |
8,889,500 |
| Beta |
1.289 |
| Bid |
65.65 |
| Bid Size |
2 |
| Board Risk |
1 |
| Book Value |
13.323 |
| City |
Minneapolis |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
10 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
71.36 |
| Current Ratio |
4.489 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
71.49 |
| Day Low |
71.1 |
| Debt To Equity |
13.922 |
| Display Name |
Bio-Techne |
| Dividend Date |
1,780,012,800 |
| Dividend Rate |
0.32 |
| Dividend Yield |
0.45 |
| Earnings Call Timestamp End |
1,778,072,400 |
| Earnings Call Timestamp Start |
1,778,072,400 |
| Earnings Growth |
1.286 |
| Earnings Quarterly Growth |
1.26 |
| Earnings Timestamp |
1,778,070,600 |
| Earnings Timestamp End |
1,785,933,000 |
| Earnings Timestamp Start |
1,785,933,000 |
| Ebitda |
366,044,992 |
| Ebitda Margins |
0.30231002 |
| Enterprise To Ebitda |
30.731 |
| Enterprise To Revenue |
9.29 |
| Enterprise Value |
11,248,954,368 |
| Eps Current Year |
1.91914 |
| Eps Forward |
2.04528 |
| Eps Trailing Twelve Months |
0.7 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,779,062,400 |
| Exchange |
NMS |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
612 656 4400 |
| Fifty Day Average |
55.5798 |
| Fifty Day Average Change |
15.780201 |
| Fifty Day Average Change Percent |
0.28391972 |
| Fifty Two Week Change Percent |
35.49981 |
| Fifty Two Week High |
72.16 |
| Fifty Two Week High Change |
-0.80000305 |
| Fifty Two Week High Change Percent |
-0.011086516 |
| Fifty Two Week Low |
43.2 |
| Fifty Two Week Low Change |
28.16 |
| Fifty Two Week Low Change Percent |
0.65185183 |
| Fifty Two Week Range |
43.2 - 72.16 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
603,037,800,000 |
| Five Year Avg Dividend Yield |
0.44 |
| Float Shares |
155,961,264 |
| Forward Eps |
2.04528 |
| Forward P E |
34.89009 |
| Free Cashflow |
299,849,376 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
3,100 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.66399 |
| Gross Profits |
803,971,968 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00306 |
| Held Percent Institutions |
1.18258 |
| Implied Shares Outstanding |
155,810,652 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ir Website |
http://www.techne-corp.com/ |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,779,062,400 |
| Last Dividend Value |
0.08 |
| Last Fiscal Year End |
1,751,241,600 |
| Last Split Date |
1,669,766,400 |
| Last Split Factor |
4:1 |
| Long Business Summary |
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota. |
| Long Name |
Bio-Techne Corporation |
| Market |
us_market |
| Market Cap |
11,118,648,320 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_189488 |
| Most Recent Quarter |
1,774,915,200 |
| Net Income To Common |
109,499,000 |
| Next Fiscal Year End |
1,782,777,600 |
| Non Diluted Market Cap |
11,109,299,487 |
| Number Of Analyst Opinions |
12 |
| Open |
71.1 |
| Operating Cashflow |
294,857,984 |
| Operating Margins |
0.25191 |
| Overall Risk |
8 |
| Payout Ratio |
0.4571 |
| Peg Ratio |
0.96 |
| Phone |
612 379 8854 |
| Previous Close |
71.3 |
| Price Eps Current Year |
37.183323 |
| Price Hint |
2 |
| Price To Book |
5.356151 |
| Price To Sales Trailing12 Months |
9.182811 |
| Profit Margins |
0.09049 |
| Quick Ratio |
2.797 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
hold |
| Recommendation Mean |
2.73333 |
| Region |
US |
| Regular Market Change |
0.0599976 |
| Regular Market Change Percent |
0.084148 |
| Regular Market Day High |
71.49 |
| Regular Market Day Low |
71.1 |
| Regular Market Day Range |
71.1 - 71.49 |
| Regular Market Open |
71.1 |
| Regular Market Previous Close |
71.3 |
| Regular Market Price |
71.36 |
| Regular Market Time |
1,783,972,800 |
| Regular Market Volume |
2,176,582 |
| Return On Assets |
0.07452 |
| Return On Equity |
0.053400002 |
| Revenue Growth |
-0.015 |
| Revenue Per Share |
7.769 |
| Sand P52 Week Change |
0.20847368 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
1 |
| Shares Outstanding |
155,810,652 |
| Shares Percent Shares Out |
0.1021 |
| Shares Short |
15,915,631 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
13,846,089 |
| Short Name |
Bio-Techne Corp |
| Short Percent Of Float |
0.1166 |
| Short Ratio |
2.32 |
| Source Interval |
15 |
| State |
MN |
| Symbol |
TECH |
| Target High Price |
73.0 |
| Target Low Price |
50.0 |
| Target Mean Price |
70.0 |
| Target Median Price |
73.0 |
| Total Cash |
214,114,000 |
| Total Cash Per Share |
1.368 |
| Total Debt |
290,321,984 |
| Total Revenue |
1,210,811,008 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.32 |
| Trailing Annual Dividend Yield |
0.0044880784 |
| Trailing Eps |
0.7 |
| Trailing P E |
101.94286 |
| Trailing Peg Ratio |
0.9559 |
| Triggerable |
1 |
| Two Hundred Day Average |
58.54635 |
| Two Hundred Day Average Change |
12.813652 |
| Two Hundred Day Average Change Percent |
0.21886338 |
| Type Disp |
Equity |
| Volume |
2,176,582 |
| Website |
https://www.bio-techne.com |
| Zip |
55,413 |